Free Trial

Silo Pharma (SILO) Competitors

Silo Pharma logo
$0.40 +0.01 (+2.81%)
As of 11:28 AM Eastern

SILO vs. PMNT, EVKG, ONON, AS, and LULU

Should you buy Silo Pharma stock or one of its competitors? MarketBeat compares Silo Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), Amer Sports (AS), and lululemon athletica (LULU). These companies are all part of the "apparel" industry.

How does Silo Pharma compare to Perfect Moment?

Silo Pharma (NASDAQ:SILO) and Perfect Moment (NASDAQ:PMNT) are both small-cap apparel companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,726.39%. Silo Pharma's return on equity of -88.40% beat Perfect Moment's return on equity.

Company Net Margins Return on Equity Return on Assets
Silo Pharma-6,726.39% -88.40% -70.03%
Perfect Moment -67.38%-513.83%-119.38%

Silo Pharma has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market. Comparatively, Perfect Moment has a beta of -1.89, indicating that its share price is 289% less volatile than the broader market.

5.6% of Silo Pharma shares are owned by institutional investors. Comparatively, 23.0% of Perfect Moment shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by insiders. Comparatively, 22.2% of Perfect Moment shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Silo Pharma had 1 more articles in the media than Perfect Moment. MarketBeat recorded 1 mentions for Silo Pharma and 0 mentions for Perfect Moment. Silo Pharma's average media sentiment score of 0.00 equaled Perfect Moment'saverage media sentiment score.

Company Overall Sentiment
Silo Pharma Neutral
Perfect Moment Neutral

Perfect Moment has a consensus price target of $1.50, suggesting a potential upside of 564.89%. Given Perfect Moment's stronger consensus rating and higher possible upside, analysts clearly believe Perfect Moment is more favorable than Silo Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Perfect Moment
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Silo Pharma has higher earnings, but lower revenue than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silo Pharma$70K93.44-$4.23M-$0.43N/A
Perfect Moment$22.93M0.46-$8.72M-$0.72N/A

Summary

Perfect Moment beats Silo Pharma on 8 of the 15 factors compared between the two stocks.

How does Silo Pharma compare to Ever-Glory International Group?

Silo Pharma (NASDAQ:SILO) and Ever-Glory International Group (NASDAQ:EVKG) are both small-cap apparel companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Silo Pharma has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market. Comparatively, Ever-Glory International Group has a beta of 5.3, indicating that its share price is 430% more volatile than the broader market.

In the previous week, Silo Pharma had 1 more articles in the media than Ever-Glory International Group. MarketBeat recorded 1 mentions for Silo Pharma and 0 mentions for Ever-Glory International Group. Silo Pharma's average media sentiment score of 0.00 equaled Ever-Glory International Group'saverage media sentiment score.

Company Overall Sentiment
Silo Pharma Neutral
Ever-Glory International Group Neutral

Ever-Glory International Group has a net margin of 0.00% compared to Silo Pharma's net margin of -6,726.39%. Ever-Glory International Group's return on equity of 0.00% beat Silo Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Silo Pharma-6,726.39% -88.40% -70.03%
Ever-Glory International Group N/A N/A N/A

5.6% of Silo Pharma shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by insiders. Comparatively, 35.5% of Ever-Glory International Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Ever-Glory International Group has lower revenue, but higher earnings than Silo Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silo Pharma$70K93.44-$4.23M-$0.43N/A
Ever-Glory International GroupN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ever-Glory International Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Ever-Glory International Group beats Silo Pharma on 6 of the 10 factors compared between the two stocks.

How does Silo Pharma compare to ON?

ON (NYSE:ONON) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

ON has a net margin of 7.92% compared to Silo Pharma's net margin of -6,726.39%. ON's return on equity of 15.72% beat Silo Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
ON7.92% 15.72% 8.99%
Silo Pharma -6,726.39%-88.40%-70.03%

ON currently has a consensus price target of $55.05, suggesting a potential upside of 37.67%. Given ON's stronger consensus rating and higher probable upside, analysts clearly believe ON is more favorable than Silo Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ON
1 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
2.82
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, ON had 6 more articles in the media than Silo Pharma. MarketBeat recorded 7 mentions for ON and 1 mentions for Silo Pharma. ON's average media sentiment score of 0.66 beat Silo Pharma's score of 0.00 indicating that ON is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ON
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

36.4% of ON shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 68.6% of ON shares are held by company insiders. Comparatively, 2.2% of Silo Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

ON has a beta of 2.09, suggesting that its stock price is 109% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.65, suggesting that its stock price is 35% less volatile than the broader market.

ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ON$3.64B7.02$245.87M$0.9343.00
Silo Pharma$70K93.44-$4.23M-$0.43N/A

Summary

ON beats Silo Pharma on 16 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to Amer Sports?

Amer Sports (NYSE:AS) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Amer Sports presently has a consensus target price of $48.19, suggesting a potential upside of 31.82%. Given Amer Sports' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amer Sports is more favorable than Silo Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amer Sports
0 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
2 Strong Buy rating(s)
3.00
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Amer Sports had 13 more articles in the media than Silo Pharma. MarketBeat recorded 14 mentions for Amer Sports and 1 mentions for Silo Pharma. Amer Sports' average media sentiment score of 0.57 beat Silo Pharma's score of 0.00 indicating that Amer Sports is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amer Sports
5 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

40.3% of Amer Sports shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Amer Sports has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amer Sports$6.57B3.08$427.40M$0.8045.70
Silo Pharma$70K93.44-$4.23M-$0.43N/A

Amer Sports has a net margin of 6.50% compared to Silo Pharma's net margin of -6,726.39%. Amer Sports' return on equity of 10.29% beat Silo Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Amer Sports6.50% 10.29% 6.30%
Silo Pharma -6,726.39%-88.40%-70.03%

Summary

Amer Sports beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to lululemon athletica?

lululemon athletica (NASDAQ:LULU) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

lululemon athletica has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than lululemon athletica, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
lululemon athletica$11.10B1.38$1.58B$13.309.52
Silo Pharma$70K93.44-$4.23M-$0.43N/A

lululemon athletica has a net margin of 14.22% compared to Silo Pharma's net margin of -6,726.39%. lululemon athletica's return on equity of 34.82% beat Silo Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
lululemon athletica14.22% 34.82% 20.14%
Silo Pharma -6,726.39%-88.40%-70.03%

85.2% of lululemon athletica shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 0.5% of lululemon athletica shares are held by insiders. Comparatively, 2.2% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

lululemon athletica has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market.

lululemon athletica currently has a consensus price target of $201.66, indicating a potential upside of 59.25%. Given lululemon athletica's stronger consensus rating and higher possible upside, equities research analysts plainly believe lululemon athletica is more favorable than Silo Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
lululemon athletica
2 Sell rating(s)
28 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.06
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, lululemon athletica had 29 more articles in the media than Silo Pharma. MarketBeat recorded 30 mentions for lululemon athletica and 1 mentions for Silo Pharma. lululemon athletica's average media sentiment score of 0.32 beat Silo Pharma's score of 0.00 indicating that lululemon athletica is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
lululemon athletica
10 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
5 Negative mention(s)
5 Very Negative mention(s)
Neutral
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

lululemon athletica beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

Get Silo Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SILO vs. The Competition

MetricSilo PharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$6.54M$3.37B$6.39B$12.49B
Dividend YieldN/A2.27%2.76%5.28%
P/E Ratio-0.9318.7820.9825.81
Price / Sales93.44330.26559.6387.99
Price / CashN/A125.1743.4956.67
Price / Book1.157.1110.417.22
Net Income-$4.23M$24.45M$3.57B$335.78M
7 Day Performance7.77%7.15%4.39%4.46%
1 Month Performance-19.60%2.79%1.84%3.07%
1 Year Performance-6.27%64.11%34.86%37.79%

Silo Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SILO
Silo Pharma
0.1654 of 5 stars
$0.40
+2.8%
N/A-8.8%$6.54M$70KN/A2
PMNT
Perfect Moment
1.3973 of 5 stars
$0.23
+1.9%
$1.50
+566.7%
-64.5%$10.55M$22.93MN/A31
EVKG
Ever-Glory International Group
N/A$0.00
flat
N/AN/A$3KN/AN/A4,300
ONON
ON
4.946 of 5 stars
$37.82
+1.3%
$55.05
+45.6%
-32.0%$23.83B$3.12B40.663,963
AS
Amer Sports
4.7114 of 5 stars
$34.84
+3.0%
$48.19
+38.3%
-5.0%$18.74B$6.57B43.5515,400

Related Companies and Tools


This page (NASDAQ:SILO) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners